Vanda Pharmaceuticals (VNDA) P/E US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| P/E | ? | 26.3 | 66.5 | 96.5 | -14.7 | -2.36 | -1.43 | |
| Changes by years, y/y, % | -14% | +153% | +45% | -115% | -84% | |||
Vanda Pharmaceuticals. P/E
Vanda Pharmaceuticals. P/E, changes, %
Vanda Pharmaceuticals (VNDA) P/E US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q1 | LTM ? | |||
| P/E | ? | -4.16 | -3.49 | -2.36 | -1.72 | -1.72 | -1.43 | |
| Changes by years, y/y, % | -86% | -79% | -84% | -72% | -72% | |||
| Changes by quarters, q/q, % | -31% | -16% | -32% | -27% | 0% | |||